Table 1.
Dose (mg kg−1) | Treatment | Method | N | Body weight (kg) | Perfusate concentration (ng ml−1) | ||
---|---|---|---|---|---|---|---|
0 | 50 | 500 | |||||
4 | Vehicle | EEG | 7 | 0.294±0.023 | N/A | N/A | N/A |
EEG/MD | 14 | 0.297±0.014 | N=10 | N=3 | N=3 | ||
MD | 3 | 0.304±0.023 | N=3 | ||||
GF120918 | EEG/MD | 20 | 0.300±0.030 | N=10 | N=5 | N=5 | |
10 | Vehicle | EEG | 7 | 0.260±0.015 | N/A | N/A | N/A |
40 | Vehicle | EEG | 5 | 0.273±0.026 | N/A | N/A | N/A |
EEG/MD | 15 | 0.306±0.019 | N=9 | N=3 | N=3 |
Abbreviations: EEG,electroencephalogram; MD, multidrug resistance; N/A, not applicable.